Turning Slurry Into a Resource: Veterinary Europe Holder by WorldPathol’s Practical Circular Approach

As part of the Desafía AgTech Germany program, Veterinary Europe Holder by WorldPathol introduces its work at the intersection of biotechnology, animal health, and circular farm systems. The program supports selected Spanish AgTech startups with access to German's AgTech ecosystem. In this interview, WorldPathol outlines how its integrated approach strengthens animal health, reduces environmental impact, and builds more resilient protein supply chains.

Can you explain, in simple terms, what you actually do and how biotechnology, animal health, and environmental management come together in one system?

At WorldPathol, we’ve built a unique biotechnology platform that connects animal health, environmental care, and farm profitability into one integrated system. Our mission is simple: to protect the future of protein supply chains, starting at the farm level. We do this by transforming two major challenges: slurry waste and disease outbreaks into opportunities for sustainability and innovation:

1. Environmental Management: Using our patented EMRA technology, we convert slurry (animal waste) into biofertilizer free of antibiotic resistance genes, drastically reducing carbon emissions and turning a cost into a valuable product.
   
   
2. Animal Health: With our TRIVAC platform, we monitor slurry to detect disease patterns and deliver tailored, multivalent vaccines farm-by-farm. This proactive approach improves welfare, reduces mortality, and cuts antibiotic use.
   
   
3. Biotechnology Backbone: Both systems are powered by real-time diagnostics, genetic surveillance, and patented innovations that allow us to close the loop between waste, health, and productivity.

The result? Farms become cleaner, animals healthier, and food production more resilient, while generating new revenue streams and reducing environmental impact. It’s One Health in action, with measurable gains in carbon reduction, yield, and profitability.

What does your company name "Veterinary Europe Holder by Worldpathol" stand for, and how does it reflect your mission?

The name Veterinary Europe Holder is a working title that reflects the essence of our integrated mission. While we’re open to rebranding, each word was chosen with purpose:

• Veterinary highlights our commitment to animal health and welfare—not just as a clinical goal, but as a driver of environmental care and food system resilience.
  
  
• Europe signals our origin and alignment with the Made in Europe values: quality, traceability, and sustainability. It also reflects our ambition to scale across European protein supply chains.
  
  
• Holder suggests a centralized, strategic vehicle—one that consolidates key assets (patents, technologies, partnerships) to deliver impact at scale. It’s not just a name, but a structure for long-term industrial collaboration.

Together, the name represents our vision: to create a European hub for veterinary innovation that connects farms, regulators, and biotech partners in a shared mission to protect food security, reduce carbon and improve animal welfare.

The idea of connecting veterinary science with circular agriculture is quite novel. What inspired that intersection?

At WorldPathol, this intersection isn’t new, it’s our foundation. We were born 15 years ago. From the beginning, we’ve seen veterinary science not just as a tool for treating animals, but as a strategic lever for improving farm profitability, reducing environmental impact, and protecting public health. Circular agriculture gave us the framework to do that: by turning waste into value, and disease surveillance into prevention.

Our inspiration came from the farm itself. We listened to farmers, studied their challenges, and realized that slurry, mortality, and antibiotic resistance weren’t isolated problems, they were symptoms of a broken system. So we built a platform that connects slurry transformation, tailored vaccination, and carbon reduction into one circular model. It’s not just about innovation, it’s about reimagining agriculture as a regenerative system, where veterinary science drives sustainability and resilience from the ground up.

Circular systems like yours can sound complex. What’s one simple example that shows how your approach works from start to finish?

Let’s take our experimental farm with 200 sows as a real-life example. It’s a closed-cycle system where we’ve validated our entire approach—from waste to wellness.

1. It starts with slurry—the manure produced by pigs. Instead of treating it as waste, we monitor it continuously. This gives us early warning signs of disease and helps us understand the farm’s health status.
   
   
2. Based on what we find, we design custom vaccines for that specific farm. For example, we’ve successfully vaccinated against Glässer’s disease and porcine circovirus using this method. We’ve also tested vaccines for rotavirus, atypical pestivirus, and PRRS.
   
   
3. Meanwhile, the slurry itself is transformed into a biofertilizer free of antibiotic resistance genes, thanks to our EMRA technology. This reduces carbon emissions and creates a safe, valuable product for crops.
   
   
4. The result? Healthier pigs, lower mortality, less antibiotic use, and a cleaner environment—all while improving farm profitability.

It’s a full circle: waste becomes an income -biofetilizer and a diagnostic tool, vaccines become tailored solutions, and the farm becomes more sustainable and resilient. And we’ve proven it works, right on the ground.

You’re currently taking part in the Desafía Agtech Germany program. What attracted you to the German market in particular?

Germany is the largest swine producer in Europe and one of the most demanding markets when it comes to sustainability, traceability, and innovation. For us, that’s not a challenge, t’s a perfect fit. German regulators, farmers, and consumers are deeply committed to reducing antibiotic use, cutting carbon emissions, and improving animal welfare. These are exactly the goals our technology was built to achieve. We’ve already validated our circular system on our experimental farm, and Germany offers the ideal environment to scale it up with an industrial partner.

The market is open to proven, science-backed solutions, and we bring two patented platformsEMRA and TRIVAC, that deliver measurable impact. We couldn’t imagine a better place to connect with forward-thinking partners who want to lead the next generation of sustainable protein production.

What are you hoping to learn or achieve through the Desafía Agtech Germany program?

Through Desafía Agtech Germany, we’re looking for more than just market access, we’re searching for a long-term industrial partner who shares our vision. We want to connect with a reliable customer, a validator, and an open-minded early adopter who understands the urgency of transforming swine and biogas production. Germany offers the perfect ecosystem: strong regulation, forward-thinking farmers, and a market that rewards validated innovation.

Our goal is to accelerate the deployment of our circular system, where slurry becomes biofertilizer, and disease surveillance leads to tailored vaccination at industrial scale. We’ve proven the concept on our experimental farm. Now, we want to scale it with someone who’s ready to lead change, not just follow it. Desafía gives us the platform to learn from the German market, build trust, and find the right partner to co-create the future of sustainable protein production.